S&P Global Ratings Upgrades Teva to 'BB+' Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
The two updates underscore Teva's strong execution of its Pivot to Growth strategy and commitment to financial discipline. Moody's affirmed Teva's B1a rating and revised Teva's outlook to positive from stable S&P upgraded Teva to BB+ from BB, with a stable ou
(Financial Post, 2025-12-24T13:39:42Z)